We are live on ! Find out more
BC

BIT Capital Portfolio holdings

AUM $2.07B
1-Year Est. Return 157.17%
This Fund
S&P 500
This Quarter Est. Return
-3.1%
1 Year Est. Return
+157.17%
3 Year Est. Return
+781.63%
5 Year Est. Return
+899.06%
10 Year Est. Return
–
AUM
$855M
AUM Growth
-$224M
Cap. Flow
-$143M
Cap. Flow %
-16.72%
Top 10 Hldgs %
58.19%
Holding
167
New
30
Increased
34
Reduced
31
Closed
45

Top Buys

Rank Stock Value
1
AFRM icon
Affirm
AFRM
+$39.1M
2
SE icon
Sea Limited
SE
+$18.4M
3
PGY icon
Pagaya Technologies
PGY
+$13.4M
4
DUOL icon
Duolingo
DUOL
+$12.3M
5
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
+$10.8M

Top Sells

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$37.7M
2
NVDA icon
NVIDIA
NVDA
+$26.2M
3
PANW icon
Palo Alto Networks
PANW
+$19.3M
4
HIMS icon
Hims & Hers Health
HIMS
+$18.8M
5
OPEN icon
Opendoor
OPEN
+$16.7M

Sector Composition

Rank Sector Weight
1 Financials 32.38%
2 Technology 28.29%
3 Consumer Discretionary 11.59%
4 Healthcare 7.3%
5 Communication Services 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIVE
76
HIVE Digital Technologies
HIVE
$762M
$345K 0.04%
111,900
-50,065
-31% -$213K
RUN icon
77
Sunrun
RUN
$2.83B
$279K 0.03%
22,221
-46,525
-68% -$765K
HUT
78
Hut 8
HUT
$10.3B
$259K 0.03%
26,555
-19,128
-42% -$272K
LILMW
79
DELISTED
Lilium N.V. Warrants
LILMW
$254K 0.03%
+2,115,384
New +$407K
VRNA
80
DELISTED
Verona Pharma
VRNA
$253K 0.03%
15,500
+2,500
+19% +$48.1K
BLUE
81
DELISTED
bluebird bio
BLUE
$245K 0.03%
4,058
– –
KROS icon
82
Keros Therapeutics
KROS
$211M
$222K 0.03%
6,962
– –
AKRO
83
DELISTED
Akero Therapeutics
AKRO
$216K 0.03%
4,276
– –
KRTX
84
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$210K 0.02%
1,241
– –
IMCR icon
85
Immunocore
IMCR
$1.78B
$208K 0.02%
4,003
– –
BPMC
86
DELISTED
Blueprint Medicines
BPMC
$205K 0.02%
4,074
+1,219
+43% +$65.1K
SRRK icon
87
Scholar Rock
SRRK
$6.33B
$201K 0.02%
28,367
– –
LAZR
88
DELISTED
Luminar Technologies
LAZR
$180K 0.02%
+1,051
New +$96.4K
CBAY
89
DELISTED
Cymabay Therapeutics
CBAY
$169K 0.02%
+11,328
New +$150K
BBIO icon
90
BridgeBio Pharma
BBIO
$15.9B
$168K 0.02%
+6,357
New +$180K
EWTX icon
91
Edgewise Therapeutics
EWTX
$4.28B
$136K 0.02%
23,715
+5,052
+27% +$34.3K
ATAI icon
92
AtaiBeckley Inc
ATAI
$2.66B
$133K 0.02%
103,232
– –
CWEN.A
93
DELISTED
Clearway Energy Class A
CWEN.A
$129K 0.02%
+6,477
New +$155K
APTV icon
94
Aptiv
APTV
$12.2B
$127K 0.01%
+1,287
New +$133K
INZY
95
DELISTED
Inozyme Pharma
INZY
$122K 0.01%
29,129
– –
RPTX
96
DELISTED
Repare Therapeutics
RPTX
$118K 0.01%
+9,766
New +$101K
HOOK
97
DELISTED
HOOKIPA Pharma
HOOK
$115K 0.01%
18,747
+9,076
+94% +$66.6K
SDGR icon
98
Schrodinger
SDGR
$1.14B
$110K 0.01%
3,886
+1,186
+44% +$47.8K
XNCR icon
99
Xencor
XNCR
$1.3B
$109K 0.01%
5,418
– –
REPL icon
100
Replimune Group
REPL
$859M
$101K 0.01%
5,912
-1,261
-18% -$24.8K
2 3
4
5 6

Similar funds

HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.07B AUM 19% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.07B AUM 4.33% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
3AM
3EDGE Asset Management Naples, Florida $2.07B AUM 16.66% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

BIT Capital's Q3 2023 Portfolio in Review

As of Q3 2023, BIT Capital held 167 positions worth $855M, down 21% from $1.08B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

BIT Capital withdrew a net $143M in Q3 2023, closing 45 positions and reducing 31 holdings. Its most notable exit was Carvana, an estimated $37.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, BIT Capital opened a new position in Affirm worth $45.5M.

  • BIT Capital's largest Q3 2023 buy was Affirm: 2,140,113 shares worth $45.5M.
  • BIT Capital added most to Sea Limited in Q3 2023, an estimated $18.4M increase.
  • BIT Capital's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $26.2M.
  • BIT Capital fully exited Carvana in Q3 2023, selling an estimated $37.7M.
  • BIT Capital's ten largest holdings make up 58% of its $855M portfolio in Q3 2023.
  • BIT Capital opened 30 new positions and closed 45 in Q3 2023.
  • BIT Capital's portfolio value fell 21% quarter-over-quarter to $855M.

Based on BIT Capital's 13F filing for Q3 2023, filed 12 Feb 2025.